Related Experiment Video

Updated: Aug 16, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

Could p53 be a target for therapeutic suppression?

E A Komarova1, A V Gudkov

  • 1Department of Molecular Genetics, University of Illinois at Chicago 60607, USA.

Seminars in Cancer Biology
|April 2, 1999
PubMed

Insights

The tumor suppressor p53 causes normal tissue damage during cancer therapy. Suppressing p53 may protect tissues from genotoxic stress and aid recovery, but requires careful consideration of its developmental roles.

Area of Science:

  • Molecular Biology
  • Oncology
  • Radiology

Background:

  • The tumor suppressor protein p53 traditionally protects against cancer by inducing growth arrest and apoptosis.
  • However, p53's functions can cause normal tissue damage during genotoxic cancer therapies.
  • This suggests p53 inhibition as a strategy to mitigate treatment side effects.

Purpose of the Study:

  • To analyze the role of p53 in acute and long-term consequences of genotoxic stress in vivo.
  • To evaluate the potential of therapeutic p53 suppression for protecting normal tissues during cancer treatment.

Main Methods:

  • Comparison of p53 wild type and p53-deficient mice exposed to genotoxic stress (gamma irradiation).
  • Analysis of tissue-specific apoptosis patterns and p53 mRNA expression.
  • Assessment of hematopoietic system and epithelial recovery post-irradiation.

Main Results:

  • p53 mediates significant apoptosis in radiosensitive tissues shortly after gamma irradiation.
  • Tissue sensitivity correlates with p53 mRNA expression levels.
  • p53 suppression is crucial for hematopoietic stem and differentiating cell survival and recovery.
  • p53-independent apoptosis occurs in radiosensitive epithelial stem cells, unaffected by p53 status.

Conclusions:

  • p53 plays a critical role in mediating normal tissue damage from genotoxic stress, particularly in the hematopoietic system.
  • Therapeutic suppression of p53 could protect normal tissues and enhance recovery after anti-cancer therapy.
  • Potential complications related to p53's role in normal development must be considered.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...